Rankings
▼
Calendar
PHIO Q2 2025 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
Q2 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1M
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-0.45
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$51,000
Balance Sheet
Total Assets
$11M
Total Liabilities
$1M
Stockholders' Equity
$10M
Cash & Equivalents
$11M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$1M
-$866,000
-24.0%
Operating Income
-$2M
-$2M
-20.6%
Net Income
-$2M
-$2M
-17.3%
← FY 2025
All Quarters
Q3 2025 →